3 Reasons to Avoid SpaceX Stock When It IPOs

SpaceX is reported to be preparing a June IPO at an expected valuation above $2 trillion, but the article argues investors should be cautious. It cites nearly $5 billion in 2025 losses tied to the $250 billion acquisition of xAI, slowing revenue growth to 18% in 2025 from 51% in 2024 and 89% in 2023, and political/regulatory backlash risk tied to Elon Musk. The piece is opinionated rather than market-moving, and frames the IPO as high-risk for retail investors.

Analysis

The market is likely mispricing this as a simple “space winner” IPO when the more important issue is capital allocation quality. If the company is forced to fund a second, highly capital-intensive platform while its core business is decelerating, the public listing becomes a financing event for optionality rather than a clean monetization of earnings power. That tends to compress multiple expansion over the first 6-12 months because investors re-rate around burn, dilution risk, and management attention instead of the headline valuation.

Second-order effects matter more here than the direct ticker exposure. A high-profile listing at a massive valuation can pull incremental capital away from adjacent private-space names and late-stage AI infrastructure winners, but it also raises the bar for every unprofitable growth story in the market. If the IPO trades poorly, expect a brief chill in private-markets pricing and a tougher read-through for future mega-rounds, especially where the business case depends on heavy capex and regulatory goodwill.

The political overhang is not just reputational; it is a practical operating risk with a long fuse. The key catalyst window is 3-18 months, when contract renewals, launch approvals, and local permitting decisions can start reflecting accumulated backlash. That makes the stock vulnerable to a “slow bleed” scenario rather than an immediate collapse: price action may hold initially, then weaken as regulatory friction and customer concentration become visible in reported KPIs.

The contrarian case is that the pessimism may already be partially embedded if the IPO is priced as an iconic scarcity asset. In that scenario, the right trade is not an outright binary short on day one, but a patience trade against enthusiasm decaying once lockup, quarterly guidance, and capex commentary reveal how much growth is being sacrificed for strategic experimentation. The cleanest edge is to separate the durable business from the speculative narrative and fade the parts of the story that require perfect execution across politics, AI, and capital markets simultaneously.

Key Decisions for Investors

• Avoid buying the IPO in the first 1-2 quarters post-listing; wait for the first two earnings prints to assess whether margin pressure and cash burn are stabilizing or compounding.
• If options are liquid, consider a 6-12 month put spread on the post-IPO name once implied volatility normalizes; the thesis is multiple compression as growth decelerates and capex expands.
• Pair trade: long NVDA / short the IPO once it lists, on the view that AI capex beneficiaries with proven monetization should outperform AI capex consumers if spending remains elevated over the next 6-12 months.
• For TSLA holders, reduce exposure or hedge into political headline risk via collars over the next 3-9 months; the risk is not immediate demand shock but worsening regulatory and brand friction.
• Monitor AAPL and META only as sentiment comparables: if the IPO weakens peer multiples, use any broad AI/growth selloff to add selectively to profitable platforms rather than speculative capital burners.